Your browser doesn't support javascript.
loading
Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer.
Couderc, Anne-Laure; Ninove, Laetitia; Nouguerède, Emilie; Rey, Dominique; Rebroin, Marina; Daumas, Aurélie; Tomasini, Pascale; Greillier, Laurent; Salas, Sebastien; Duffaud, Florence; Dahan, Laetitia; Duluc, Muriel; Garcia, Marie-Eve; Pluvy, Johan; Chaléat, Solène; Farnault, Laure; Venton, Geoffroy; Fourié, Toscane; Nurtop, Elif; de Lamballerie, Xavier; Villani, Patrick; Charrel, Remi; Correard, Florian.
Affiliation
  • Couderc AL; Internal Medicine, Geriatrics and Therapeutic Unit, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France; Aix-Marseille University, CNRS, EFS, ADES, Marseille, France; Coordination Unit for Geriatric Oncology (UCOG), PACA West, France. Electronic address: anne-laure.couderc@ap-hm.fr.
  • Ninove L; Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, 13005 Marseille, France.
  • Nouguerède E; Internal Medicine, Geriatrics and Therapeutic Unit, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France; Coordination Unit for Geriatric Oncology (UCOG), PACA West, France.
  • Rey D; Internal Medicine, Geriatrics and Therapeutic Unit, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France; Coordination Unit for Geriatric Oncology (UCOG), PACA West, France.
  • Rebroin M; Pharmacy Department, AP-HM, Marseille, France.
  • Daumas A; Internal Medicine, Geriatrics and Therapeutic Unit, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Tomasini P; Multidisciplinary Oncology and Therapeutic Innovations Department, AP-HM, Marseille, France.
  • Greillier L; Multidisciplinary Oncology and Therapeutic Innovations Department, AP-HM, Marseille, France.
  • Salas S; Oncology Unit, AP-HM, Marseille, France.
  • Duffaud F; Oncology Unit, AP-HM, Marseille, France.
  • Dahan L; Hepato-Gastro-Enterolgy Unit, CHU Timone, AP-HM, Marseille, France.
  • Duluc M; Hepato-Gastro-Enterolgy Unit, CHU Timone, AP-HM, Marseille, France.
  • Garcia ME; Multidisciplinary Oncology and Therapeutic Innovations Department, AP-HM, Marseille, France.
  • Pluvy J; Multidisciplinary Oncology and Therapeutic Innovations Department, AP-HM, Marseille, France.
  • Chaléat S; Multidisciplinary Oncology and Therapeutic Innovations Department, AP-HM, Marseille, France.
  • Farnault L; Haematology and Cellular Therapy Department, AP-HM, Marseille, France.
  • Venton G; Haematology and Cellular Therapy Department, AP-HM, Marseille, France.
  • Fourié T; Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, 13005 Marseille, France.
  • Nurtop E; Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, 13005 Marseille, France.
  • de Lamballerie X; Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, 13005 Marseille, France.
  • Villani P; Internal Medicine, Geriatrics and Therapeutic Unit, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France; Aix-Marseille University, CNRS, EFS, ADES, Marseille, France.
  • Charrel R; Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, 13005 Marseille, France.
  • Correard F; Pharmacy Department, AP-HM, Marseille, France.
J Geriatr Oncol ; 13(6): 850-855, 2022 07.
Article in En | MEDLINE | ID: mdl-35589542

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 / Neoplasms Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: J Geriatr Oncol Year: 2022 Document type: Article Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 / Neoplasms Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: J Geriatr Oncol Year: 2022 Document type: Article Country of publication: Países Bajos